Comments
Pharma major Dr Reddy’s Laboratories has launched Clopidogrel tablets in the US market with 180-days exclusivity.
The tablets are a bioequivalent generic version of Plavix of Bristol Myers Squibb and Sanofi SA, a blood thinner drug.
The Hyderabad-based company was among the first applicants to submit a substantially complete Abbreviated New Drug Application for Clopidogrel tablets in 300 mg capacity and was awarded 180 days of marketing exclusivity, according to a release.
The Plavix brand had US sales of approximately $6.740 billion for the most recent 12 months ended March 31, 2012, according to IMS Health.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.